Raw materials for medical textiles
1 / 18


  • Uploaded on

RAW MATERIALS FOR MEDICAL TEXTILES. 18.11.2010. Presentation Covers. Global Fibre Scenario Fibres for Technical Textiles Classification of Medical Textiles Fibres for Medical Textiles Challenges in Meditech Growth in India Recommendations. Global Fibre Production Scenario.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' RAW MATERIALS FOR MEDICAL TEXTILES' - charlotte-flynn

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Presentation Covers..

  • Global Fibre Scenario

  • Fibres for Technical Textiles

  • Classification of Medical Textiles

  • Fibres for Medical Textiles

  • Challenges in Meditech Growth in India

  • Recommendations

Global fibre production scenario
Global Fibre Production Scenario

Mn T – In Million Tons

All Fibre

78 Million T


32 Mn T



46 Mn T



1 Mn T



0.15 Mn T



24 Mn T



5.9 Mn T



43 Mn T


Cellulosic #

3.23 Mn T



31 Mn T



3.5 Mn T



1.91 Mn T



6 Mn T



1 Mn T


Tow (Acetate/ Viscose)

0.69 MnT 0.9%

Staple (Viscose)

2.13 Mn T

2.7% #

Filament (Acetate, Viscose, Cupro)

0.41 Mn T


Note :

CAGR (2001 – 08) : 3.26% as per Fibre Organon

Based on Average Production as on 2008

Fibres and their stake in meditech

Fibres and their stake in Meditech

* Source: World Fibre Report – YnFx, D&B Research

Mmf india 2 nd largest producer but

MMF - India 2nd Largest Producer, but ….

  • India’s total production of MMFs was 3.5 billion kg while global was 41 billion kg in 2007.

  • There is huge gap between China and India’s production

    • Ex- PSF – China- 76.6 / India 8.5 % - PFY – China 80.4 / India – 10.3%

    • - VSF – China – 63 / India 10.2 %

    • - Cotton – China – 7 / India 5.1 mil Tons (FY10) [in consumption china – 10.6 / India 4.2 mil Tons]

* Source: World Fibre Report – YnFx, D&B Research

Fully available

Mostly available

Not available

Fibre /Fabric/Application- Nonimplanatable

“Used for external applications and may or may contact with skin”

“Used either in the operation theatre or in the hospital wards for hygiene, care and safety of the staff and patients”

“Used in effecting repair to the body whether it is wound closure (sutures) or replacements Surgery like vascular grafts, artificial ligaments”

“Used as mechanical organs that for blood purification and include artificial kidney, the artificial liver and the mechanical lung”

Uniqueness of Fibres used in Medical Textiles

  • Pure and Hygienic

  • Bio – degradable

  • Fast & High absorbency

  • Excellent Wicking performance

  • Barrier to percolation

  • Good Insulation

  • High Strength

  • Low Lint

  • Good thermal stability

  • Soft feel

  • Excellent drape ability

  • Breathability

  • Static Dissipation

  • Engineered Specialties

    • Anti-bacterial properties

    • Medicinal clothings

  • India’s dominating fibre position supports the growth of medical textiles in India and exports of domestically produced medical textiles

    • As a consuming Hub

    • As a manufacturing Hub

  • Technology for production of most of the specialityfibres is available, but due to lack of demand, the production is negligible. Eg. – Anti Bacterial PSF/VSF

  • Hitechfibre technologies are available glogally, but needs domestic demand to make the investments workable

  • The main volume growth driver in Meditech is the Non-implantable segment which includes surgicals & healthcare/hygiene products. China leads in production capacities, while India has just arrived with considerably smaller capacities in organized sectors

  • Lack of standards and awareness among users is hindering the growth rate of Indian meditech industry

Short Term Commercial Challenges

Indian fibre producers still make available fibre and offer better prices

  • Marketing Efforts

    • Benefits of good products need to be percolated more effectively with user industry

    • Collaboration between fibre manufacturer and medi-product producer is essential

    • Encourage conversion facilities for nonwoven medi-products

    • Collective efforts of govt., research institutes and industry to cover the gap in awareness of user industry and standardization

    • Participation of manufacturers in international forums to promote Indian medi-products and establish India as a manufacturing hub

  • Product Standardization Effort

    • Standards for meditech products needs to be developed in harmony with EU/US particularly for healthcare

    • Center of excellence SITRA and its support services need to be extended to various regions

    • Nonwoven products have no mention in the product standards. For non-implantables, BIS standards as well as IP only mentions of woven products, whereas nonwovens are taking major share worldwide

    • All govt. tenders should have woven as well as nonwovens as product options for non-implantables

  • Government Levies

    • Labelling to be made mandatory and promotion of label is desired

    • DEPB / DD needs to cover the duty paid, which is absent for most of the new meditech products

    • To curb the sub-standard products and promote the local meditech industry, even mis-declaration as off-lot papers many times. Checks and controls are required

    • To promote the usage of new technology nonwoven products, the excise duty needs to be made at par with the woven products